Subscribe for FREE In their clinical study, involving 10 patients with wet AMD, the researchers first developed a method for safely removing the newly formed blood vessels followed by the ...

making it unfeasible to find these rare T cells using established wet-lab technologies and highlighting the need for more scalable AI approaches. Exogene is using its AI platform to screen TCR ...

Wet AMD in its early stages can be treated with drugs to reduce the formation of new blood vessels, but this treatment is inefficient in cases where blood vessel formation is already in its advanced ...

More information: Safe CNV removal is crucial for successful hESC-RPE transplantation in wet age-related macular degeneration, Stem Cell Reports (2025). DOI: 10.1016/j.stemcr.2025.102424.